Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase

Arthritis and Rheumatism

Volumn 56, Issue 4, 2007, Pages 1295-1303

  Hirakata, Michito ^a   Suwa, Akira ^b   Takada, Tetsuya ^a   Sato, Shinji ^a   Nagai, Sonoko ^c   Genth, Ekkehard ^d   Song, Yeong W ^e   Mimori, Tsuneyo ^c   Targoff, Ira N ^f  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e Seoul National University Hospital   (South Korea)

^f UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ASPARAGINYL TRANSFER RIBONUCLEIC ACID SYNTHETASE; AUTOANTIBODY; GENOMIC DNA; HLA ANTIGEN CLASS 2; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR2 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; INTERSTITIAL LUNG DISEASE; JAPANESE; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMYOSITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERUM;

AGED; ARTHRITIS; ASPARTATE-TRNA LIGASE; AUTOANTIBODIES; AUTOANTIGENS; DERMATOMYOSITIS; FATAL OUTCOME; FEMALE; HAPLOTYPES; HELA CELLS; HISTOCOMPATIBILITY TESTING; HLA-DR2 ANTIGEN; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMYOSITIS; RNA, TRANSFER, AMINO ACYL; SYNDROME;

EID: 34247258568     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22506     Document Type: Article

References (41)

1. Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002;28:859-90.
2. Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep 2006;8:196-203.
3. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983;304:177-9.
4. Mathews MB, Reichlin M, Hughes GR, Bernstein RM. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 1984;160:420-34.
5. Ala coexist and are associated with myositis. J Exp Med 1986;163:1281-91.
6. Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine: two additional synthetases are antigenic in myositis. J Immunol 1990;144:1737-43.
7. Targoff IN, Reichlin M. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol 1987;138:2874-82.
8. Oddis CV, Medsger TA Jr, Cooperstein LA. A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. Arthritis Rheum 1990;33:1640-5.
9. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas MC, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70:360-74.
10. Hirakata M, Mimori T, Akizuki A, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992;35:449-56.
11. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990;77:1019-38.
12. Targoff IN, Arnett FC, Reichlin M. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 1988;31:515-24.
13. Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990;88:241-51.
14. Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest 1993;91:2556-64.
15. Targoff IN, Trieu EP, Plotz PH, Miller FW. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992;35:821-30.
16. Furuya T, Hakoda M, Tsuchiya N, Kotake S, Ichikawa N, Nanke Y, et al. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. J Rheumatol 2004;31:1768-74.
17. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases: a marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983;26:604-11.
18. Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner-Warwick M, et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J 1984;289:151-2.
19. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetase in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996;26:459-67.
20. Hirakata M, Nakamura K, Okano Y, Suwa A, Inada S, Akizuki M, et al. Anti-alanyl tRNA synthetase (PL-12) antibodies are associated with interstitial lung disease in Japanese patients [abstract]. Arthritis Rheum 1995;38:S321.
21. Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996;39:1507-18.
22. Hirakata M, Suwa A, Takeda Y, Matsuoka Y, Irimajiri S, Targoff IN, et al. Autoantibodies to glycyl-transfer RNA synthetase in myositis: association with dermatomyositis and immunologic heterogeneity. Arthritis Rheum 1996;39:146-51.
23. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999;162:2315-20.
24. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
25. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
26. Targoff IN, Arnett FC, Berman L, O'Brien CA, Reichlin M. Anti-KJ: a new antibody associated with the myositis/lung syndrome that reacts with translation-related protein. J Clin Invest 1989;84:162-72.
27. Inoko H, Ota M. PCR-RFLP. In: Hui KM, Bidwell J, editors. Handbook of HLA typing techniques. Boca Raton (FL): CRC Press; 1993. p. 9-70.
28. His autoantibodies that recognize a conformational epitope in sera of patients with myositis. Arthritis Rheum 1998;41:1428-37.
29. Bunn CC, Mathews MB. Two human tRNA(Ala) families are recognized by autoantibodies in polymyositis sera. Mol Biol Med 1987;4:21-36.
30. Beaulande M, Tarbouriech N, Hartlein M. Human cytosolic asparaginyl-tRNA synthetase: cDNA sequence, functional expression in Escherichia coli and characterization as human autoantigen. Nucleic Acids Res 1998;26:521-4.
31. Miller FW, Waite KA, Biswas T, Plotz PH. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci U S A 1990;87:9933-7.
32. Schmidt WA, Wetzel W, Friedlander R, Lange R, Sorensen HF, Lichey HJ, et al. Clinical and serological aspects of patients with anti-Jo-1 antibodies: an evolving spectrum of disease manifestations. Clin Rheumatol 2000;19:371-7.
33. Sato S, Hirakata M, Kuwana M, Nakamura K, Suwa A, Inada S, et al. Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies. Clin Exp Rheumatol 2005;23:609-15.
34. Arnett FC. The genetics of human lupus. In: Wallace DL, Hahn BH, editors. Dubois' lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins; 1997. p.77-117.
35. Hirakata M, Satoh S, Suwa A, Nakamura K, Hama N, Ohsone Y, et al. Clinical and immunogenetic features of anti-aminoacyl tRNA synthetase autoantibodies in Japanese patients [abstract]. Arthritis Rheum 1997;40 Suppl 9:S83.
36. Hirakata M, Suwa A, Kuwana M, Sato S, Mimori T, Hardin JA. Association between autoantibodies to the Ku protein and DPB1. Arthritis Rheum 2005;52:668-9.
37. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111:143-57.
38. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW. Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995;38:437-9.
39. Plotz PH. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 1983;2:824-6.
40. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999;190:815-26.
41. Plotz PH. The autoantibody repertoire: searching for order. Nat Rev Immunol 2003;3:73-8.